Status:
UNKNOWN
The Effect of Dexmedetomidine on Kidney Function in EVAR
Lead Sponsor:
University of Thessaly
Conditions:
Acute Kidney Injury
Dexmedetomidine
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
This study will investigate the effect of dexmedetomidine on the incidence of postoperative acute kidney injury in patients undergoing EVAR under general anesthesia
Detailed Description
This study will compare the incidence of AKI after elective EVAR conducted under general anesthesia with and without administration of dexmedetomidine. The AKI will be evaluated through measuring NGAL...
Eligibility Criteria
Inclusion
- elective EVAR under general anesthesia
- adult patients 18- 85 years old
- American society of anesthesiologists (ASA) physical status I - IV
Exclusion
- refusal to participate or sign the informed consent form
- GFR \< 50ml/mim
- Bradyarrhythmia \<50/min
- Hemodynamic instability
- Known allergy to Dexmedetomidine
- Severe hepatic insufficiency
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04766047
Start Date
August 30 2021
End Date
February 1 2024
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Thessaly
Larissa, Thessaly, Greece, 41110